Cargando…

Oliceridine: A Novel Drug for the Management of Moderate to Severe Acute Pain – A Review of Current Evidence

Optimal pain relief requires a balance between adequate analgesia and risk of adverse effects. Opioids remain the cornerstone for managing moderate to severe pain, but are associated with opioid-induced respiratory depression (OIRD) and gastrointestinal complications. Opioids exert their analgesic e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Hon Sen, Habib, Ashraf S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054572/ https://www.ncbi.nlm.nih.gov/pubmed/33889018 http://dx.doi.org/10.2147/JPR.S278279

Ejemplares similares

Oliceridine for the Management of Moderate to Severe Acute Postoperative Pain: A Narrative Review
por: Daksla, Neil, et al.
Publicado: (2023)

Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults
por: Lambert, David, et al.
Publicado: (2020)

Pharmacological Advances in Opioid Therapy: A Review of the Role of Oliceridine in Pain Management
por: Kaye, Alan D., et al.
Publicado: (2021)

A Dive Into Oliceridine and Its Novel Mechanism of Action
por: Shah, Anjali, et al.
Publicado: (2021)

Oliceridine- Opioid of the 21(st) Century
por: Goudra, Basavana
Publicado: (2022)

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy
por: Bergese, Sergio D, et al.
Publicado: (2019)

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty
por: Singla, Neil, et al.
Publicado: (2017)

Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis
por: Bergese, Sergio, et al.
Publicado: (2020)

Oliceridine and its potential to revolutionize GI endoscopy sedation
por: Goudra, Basavana, et al.
Publicado: (2020)

The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine
por: Nafziger, Anne N., et al.
Publicado: (2019)

Functional bias of morphine and oliceridine under conditions of minor injury
por: Nwaneshiudu, Chinwe, et al.
Publicado: (2021)

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy
por: Viscusi, Eugene R, et al.
Publicado: (2019)

APOLLO‐2: A Randomized, Placebo and Active‐Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein–Biased Ligand at the μ‐Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty
por: Singla, Neil K., et al.
Publicado: (2019)

Low Incidence of Opioid-Induced Respiratory Depression Observed with Oliceridine Regardless of Age or Body Mass Index: Exploratory Analysis from a Phase 3 Open-Label Trial in Postsurgical Pain
por: Brzezinski, Marek, et al.
Publicado: (2021)

Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials
por: Beard, Timothy L., et al.
Publicado: (2020)

Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain
por: Ayad, Sabry, et al.
Publicado: (2020)

Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?
por: Ok, Hwoe Gyeong, et al.
Publicado: (2018)

Diagnosis, severity stratification and management of adult acute pancreatitis–current evidence and controversies
por: Chan, Kai Siang, et al.
Publicado: (2022)

Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials
por: Hammer, Gregory B., et al.
Publicado: (2021)

Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
por: Lipton, Richard B., et al.
Publicado: (2022)

A Review of the Current Clinical Evidence for Loco-Regional Moderate Hyperthermia in the Adjunct Management of Cancers
por: Chia, Brendan Seng Hup, et al.
Publicado: (2023)

Predictors for Moderate to Severe Acute Postoperative Pain after Cesarean Section
por: Borges, Natalia de Carvalho, et al.
Publicado: (2016)

Chronic postsurgical pain: current evidence for prevention and management
por: Thapa, Parineeta, et al.
Publicado: (2018)

Investigating the association factors of acute postpartum pain: a cohort study
por: Tan, Chin Wen, et al.
Publicado: (2023)

Anti-nerve growth factor in pain management: current evidence
por: Chang, David S, et al.
Publicado: (2016)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Management of moderate to severe chronic low back pain with buprenorphine buccal film using novel bioerodible mucoadhesive technology
por: Pergolizzi, Joseph V, et al.
Publicado: (2016)

Managing anesthesia for cesarean section in obese patients: current perspectives
por: Lamon, Agnes M, et al.
Publicado: (2016)

Comprehensive pain management strategy for infants with moderate to severe osteogenesis imperfecta in the perinatal period
por: Carroll, Ricki S., et al.
Publicado: (2021)

Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
por: Eissa, Ayman, et al.
Publicado: (2021)

Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Clonidine for management of chronic pain: A brief review of the current evidences
por: Kumar, Anil, et al.
Publicado: (2014)

The currency, completeness and quality of systematic reviews of acute management of moderate to severe traumatic brain injury: A comprehensive evidence map
por: Synnot, Anneliese, et al.
Publicado: (2018)

Audiological Evidence of Frequent Hereditary Mild, Moderate and Moderate-to-Severe Hearing Loss
por: Markova, Tatiana, et al.
Publicado: (2022)

Laparoscopic management of moderate: Severe endometriosis
por: Shah, Pranay R., et al.
Publicado: (2014)

Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence Study
por: Qadir, Nida, et al.
Publicado: (2021)

Managing acute abdominal pain in pediatric patients: current perspectives
por: Hijaz, Nadia M, et al.
Publicado: (2017)

Intranasal analgesia for acute moderate to severe pain in children – a systematic review and meta-analysis
por: Prescott, Marcus Glenton, et al.
Publicado: (2023)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

Effect of music listening on perioperative anxiety, acute pain and pain catastrophizing in women undergoing elective cesarean delivery: a randomized controlled trial
por: Kakde, Avinash, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m62uu5b8frateqlu13mi7dpj8e